1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Global Veterinary Infectious Disease Diagnostics Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape/Recent Development
4.4. Regulatory Framework
4.5. Porters Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Intensity of Rivalry
5. Global Veterinary Infectious Disease Diagnostics Market Overview
5.1. Market Size & Forecast by Value, 2018-2028
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Technology
5.2.1.1. Immunodiagnostics
5.2.1.1.1. Lateral Flow Assays
5.2.1.1.2. ELISA Tests
5.2.1.1.3. Other Immunodiagnostic Technologies
5.2.1.2. Molecular Diagnostics
5.2.1.2.1. Polymerase Chain Reaction (PCR) Tests
5.2.1.2.2. Microarrays
5.2.1.2.3. Other Molecular Diagnostic Tests
5.2.1.3. Others
5.2.2. By Animal Type
5.2.2.1. Companion Animals
5.2.2.2. Food Producing Animals
5.2.3. By End-User
5.2.3.1. Reference Laboratories
5.2.3.2. Veterinary Hospitals and Clinics
5.2.3.3. Point of Care / In House Testing
5.2.3.4. Research Institutes and Universities
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. The Asia Pacific
5.2.4.4. Latin America
5.2.4.5. The Middle East and Africa
6. North America Veterinary Infectious Disease Diagnostics Market
6.1. Market Size & Forecast by Value, 2018-2028
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Animal Type
6.2.3. By End-User
6.2.4. By Country
6.2.4.1. United States
6.2.4.2. Canada
7. Europe Veterinary Infectious Disease Diagnostics Market
7.1. Market Size & Forecast by Value, 2018-2028
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Animal Type
7.2.3. By End-User
7.2.4. By Country
7.2.4.1. Germany
7.2.4.2. United Kingdom
7.2.4.3. Italy
7.2.4.4. France
7.2.4.5. Spain
7.2.4.6. Rest of Europe
8. The Asia Pacific Veterinary Infectious Disease Diagnostics Market
8.1. Market Size & Forecast by Value, 2018-2028
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Animal Type
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. China
8.2.4.2. India
8.2.4.3. Japan
8.2.4.4. South Korea
8.2.4.5. Rest of Asia Pacific
9. Latin America Veterinary Infectious Disease Diagnostics Market
9.1. Market Size & Forecast by Value, 2018-2028
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Animal Type
9.2.3. By End-User
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Mexico
9.2.4.3. Rest of Latin America
10. The Middle East & Africa Global Veterinary Infectious Disease Diagnostics Market
10.1. Market Size & Forecast by Value, 2018-2028
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Animal Type
10.2.3. By End-User
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
10.2.4.4. Rest of Middle East & Africa
11. Competitive Landscape
11.1. List of Key Players and Their Offerings
11.2. Market Share Analysis, 2021
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Key Strategic Development (Merger, Acquisition, Partnership.)
12. Impact of COVID-19 on Global Veterinary Infectious Disease Diagnostics Market Industry
13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
13.1. Biomerieux S.A.
13.2. Innovative Diagnostics
13.3. IDEXX Laboratories, Inc.
13.4. Neogen Corporation
13.5. QIAGEN N.V.
13.6. Randox Laboratories, Ltd.
13.7. Thermo Fisher Scientific
13.8. Virbac
13.9. Zoetis, Inc.
13.10. Elanco
13.11. Merck & Co. Inc
13.12. Boehringer Ingelheim Vetmedica, Inc.
13.13. Bayer AG
13.14. HESKA Corporation
13.15. Demeditec Diagnostics GmbH
13.16. Other Prominent Players
14. Key Strategic Recommendations
*Financial information in case of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable